Real-world practice patterns and outcomes for RAI-refractory differentiated thyroid cancer by Andrew G Gianoukakis, Jennifer H Choe, Daniel W Bowles, Marcia S Brose, Lori J Wirth, Taofeek Owonikoko, Svetlana Babajanyan, Francis P Worden

Get full text

Phase I Trial of Radiotherapy Concurrent with Twice-Weekly Gemcitabine for Head and Neck Cancer: Translation From Preclinical Investigations Aiming to Improve the Therapeutic Ratio by Aron Popovtzer, Daniel Normolle, Francis P. Worden, Mark E. Prince, Douglas B. Chepeha, Gregory T. Wolf, Carol R. Bradford, Theodore S. Lawrence, Avraham Eisbruch

Get full text

Biomarkers predictive of response to pembrolizumab in head and neck cancer by David G. Pfister, Robert I. Haddad, Francis P. Worden, Jared Weiss, Ranee Mehra, Laura Q. M. Chow, Stephen V. Liu, Hyunseok Kang, Nabil F. Saba, Lori J. Wirth, Ammar Sukari, Erminia Massarelli, Mark Ayers, Andrew Albright, Andrea L. Webber, Robin Mogg, Jared Lunceford, Lingkang Huang, Razvan Cristescu, Jonathan Cheng, Tanguy Y. Seiwert, Joshua M. Bauml

Get full text